Dysmetabolic signals in "metabolically healthy" obesity

Obesity Research and Clinical Practice

Volumn 6, Issue 1, 2012, Pages

  Manu, Peter ^a,b   Ionescu Tirgoviste, Constantin ^d   Tsang, James ^c   Napolitano, Barbara A ^c   Lesser, Martin L ^c   Correll, Christoph U ^a,b,c  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Coronary risk; HDL cholesterol; Metabolic Health; Non HDL choleserol; Obesity

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TOBACCO SMOKE; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIETARY FIBER; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLICALLY HEALTHY OBESE; NUTRITION; OBESE WITH INSULIN RESISTANCE; OBESITY; OUTCOME ASSESSMENT; PASSIVE SMOKING; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SOCIOECONOMICS; WAIST CIRCUMFERENCE;

EID: 84856091036     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2011.04.003     Document Type: Article

References (45)

1. C.L. Ogden, M.D. Carroll, L.R. Curtin, M.A. McDowell, C.J. Tabak, and K.M. Flegal Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
2. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
3. A.C. St-Pierre, B. Cantin, P. Mauriege, J. Bergeron, G.R. Dagenais, and J.P. Despres Insulin resistance syndrome, body mass index and the risk of ischemic heart disease CMAJ 172 2005 1301 1305 (Pubitemid 40745071)
4. J.B. Meigs, M.K. Rutter, L.M. Sullivan, C.S. Fox, R.B. D'Agostino, and P.W.F. Wilson Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome Diabetes Care 30 2007 1219 1225 (Pubitemid 46684651)
5. E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, and J.B. Miegs Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population Diabetes Care 30 2007 318 324 (Pubitemid 46198337)
6. B.V. Howard, O. Ruotolo, and D.C. Robbins Obesity and dyslipidemia Endocrinol Metab Clin North Am 32 2003 855 867 (Pubitemid 38029984)
7. D.C. Chan, H.P. Barrett, and G.F. Watts Dyslipidemia in visceral obesity: mechanisms, implications and therapy Am J Cardiovasc Drugs 4 2004 227 246 (Pubitemid 39206617)
8. E.A. Sims Are there persons who are obese, but metabolically healthy? Metabolism 50 2001 1499 1504 (Pubitemid 34007425)
9. M. Brochu, A. Tchernof, I.J. Dionne, C.K. Sites, G.H. Eltabbakh, and E.A. Sims What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86 2001 1020 1025 (Pubitemid 32322976)
10. D.A. Karelis, M. Faraj, J.P. Bastard, D.H. St-Pierre, M. Brochu, and D. Prud'homme The metabolically healthy but obese individual presents a favorable inflammation profile J Clin Endocrinol Metab 90 2005 4145 4150 (Pubitemid 41058189)
11. G. Iacobellis, M.C. Ribaudo, A. Zappaterreno, C.V. Iannuci, and F. Leonetti Prevalence of uncomplicated obesity in an Italian obese population Obes Res 13 2005 1116 1122
12. R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, and J. Wylie-Rosett The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering. Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) Arch Intern Med 168 2008 1617 1624
13. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
14. S.M. Haffner, H. Miettinen, and M.P. Stern The homeostasis model in the San Antonio Heart Study Diabetes care 20 1997 1087 1092 (Pubitemid 27274268)
15. J.M. Lee, M.J. Okumura, M.M. Davis, W.H. Herman, and J.G. Gurney Prevalence and determinants of insulin resistance among U.S. adolescents Diabetes Care 29 2006 2427 2432 (Pubitemid 44912247)
16. C. Li, E.S. Ford, L.C. McGuire, A.H. Mokdad, R.R. Little, and G.M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care 29 2006 2396 2402 (Pubitemid 44912242)
17. L.S. Conwell, S.G. Trost, W.J. Brown, and J.A. Batch Indexes of insulin resistance and secretion in obese children and adolescents: a validation study Diabetes Care 27 2004 314 317
18. E. Merino-Inarra, A. Cenarro, P. Martin, A.L. Garcia-Otin, J. Goicoechea, and A. Guallar Sensitivity and specificity of metabolic syndrome criteria for insulin resistance diagnosis in Spanish population Med Clin (Barc) 128 2007 168 171 (Pubitemid 46382323)
19. R. Palacios, N. Merchante, J. Macias, M. Gonzalez, J. Castillo, and J. Ruiz Incidence of and risk factors for insulin resistance in treatment-naïve HIV-infected patients 48 weeks after starting highly active antiretroviral therapy Antivir Ther 11 2006 529 535 (Pubitemid 44024861)
20. Prospective Studies Collaboration Body-mass index and cause-specific mortality in 900000 adults; collaborative analyses of 57 prospective studies Lancet 373 2009 1083 1096
21. W. Zheng, D.F. McLerran, B. Rolland, X. Zhang, M. Inoue, and K. Matsuo Association between body-mass index and risk of death in more than 1 million Asians N Engl J Med 364 2011 719 729
22. M.H. Davidson Focusing on high-density lipoprotein for coronary heart disease risk reduction Cardiol Clin 29 2011 105 122
23. P. Muntner, F. Lee, and B.C. Astor Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities Study Am J Med Sci 2010 October 29 [Epub ahead of print]
24. M. Salminen, M. Kuoppamaki, T. Vahlber, I. Raiha, K. Irjala, and S.L. Kivela Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland Acta Diabetol 2011 January 15 [Epub ahead of print]
25. H.E. Van Deventer, W.G. Miller, G.L. Myers, I. Sakurabayashi, L.M. Bachmann, and S.P. Caudill Non-HDL choletsrol assays show improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population Clin Chem 2011 January 12 [Epub ahead of print]
26. A. Sniderman, M. McQueen, J. Contois, K. Williams, and C.D. Furberg Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol 4 2010 152 155
27. HolewijnS, M. den Heijer, D.W. Swinkels, A.F. Stalenhoef, J. de Graaf, and B. Apolipoprotein non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk J Intern Med 268 2010 567 577
28. P.P. Soderholm, G. Alfthan, A.H. Koskela, H. Adlercreutz, and M.J. Tikkanen The effect of high-fiber rye bread enriched with nonesterified plant sterols on major serum lipids and apolipoproteins in normocholesterolemic individuals Nutr Metab Cardiovasc Dis 2011 January 5 [Epub ahead of print]
29. P. Schnell-Inderst, R. Schwarzer, A. Gohler, N. Grandi, K. Grabein, and B. Stollenwerk Prognostic value, clinical effectiveness and cost effectiveness of high-density C-reactive protein as a marker for major cardiac ebents in asymptomatic individuals: a health technology assessment report Int J Technol Assess Health Care 26 2010 30 39
30. A.E. Sumner, J. Zhou, A. Doumatey, O.E. Imoisill, J. Acheampong, and J. Oli Low HDL-cholesterol with normal triglyceride levels is the most common lipid pattern in West ASfricans and African Americans with metabolic syndrome: Implications for cardiovascular disease prevention CVD Prev Control 5 2010 75 80
31. P.A. Grimaldi Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives Cell Moll Life Sci 64 2007 2459 2464 (Pubitemid 350035619)
32. S. Heikkinen, J. Auwerx, and C.A. Argmann PPARgamma in human and mouse physiology Biochim Biophys Acta 1771 2007 999 1013
33. K. Kannisto, A. Chibalin, B. Glinghammar, J.R. Zierath, A. Hamsten, and E. Ehrenborg Differential expression of peroxisomal proliferators activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise Int J Mol med 17 2006 45 52
34. P. Manu, J. Tsang, B.A. Napolitano, M.L. Lesser, and C.U. Correl Predictors of insulin resistance in the obese with metabolic syndrome Eur J Intern Med 21 2010 409 413
35. K.J. Ausk, E.J. Boyko, and G.N. Ioannou Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care 33 2010 1179 1185
36. E.L. Barr, A.J. Cameron, B. Balkau, P.Z. Zimmet, T.A. Welborn, and A.M. Tonkin HOMA insulin sensitivity index and the risk of all-cause and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study Diabetologia 53 2010 79 88
37. M.J. Blaha, A.P. Defilippis, J.J. Rivera, M.J. Budoff, R. Blankstein, and A. Agatston The relationship between insulin resistance and incidence and progression of coronary artery calcification: The Multi-Etyhnic Study of Atherosclerosis (MESA) Diabetes Care 2011 February 3 [Epub ahead of print]
38. S.J. Robins, A. Lyass, J.P. Zachariah, J.M. Massaro, and R.S. Vasan Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study Arterioscl Thromb Vasc Biol 2011 February 10 [Epub ahead of print]
39. M.K. Rutter, P.W. Wilson, L.M. Sullivan, C.S. Fox, R.B. D'Agostino, and J.B. Meigs Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease Circulation 117 2008 1003 1009
40. W. Rathmann, B. Kowall, M. Heier, C. Herder, R. Holle, and K. Straassburger Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study Diabetes Med 27 2010 1116 1123
41. R. Singh, B.R. Martin, Y. Hickey, D. Teegarden, W.W. Campbell, and B.A. Craig Comparison of self-reported, measured, metabolizable energy intake with total energy expenditure in overweight teens Am J Clin Nutr 89 2009 1744 1750
42. K.H. Pietilainen, M. Korkella, L.H. Bogl, K.R. Westerterp, H. Yki-Jarvinen, and J. Kaprio Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments Int J Obes 34 2010 437 445
43. D. Garriguet Under-reporting of energy intake in the Canadian Community Health Survey Health Rep 19 2008 37 45
44. E.K. Bothwell, G.X. Ayala, T.L. Conway, C.L. Rock, L.C. Gallo, and J.C. Elder Underreporting of food intake among Mexican/Mexican-American women: rates and correlates J Am Diet Assoc 109 2009 624 632
45. American Diabetes Association Standards of medical care in diabetes - 2010 Diabetes Care 33 Suppl. 1 2010 S11 S61